AstraZeneca PLC (AZNCF) To Go Ex-Dividend on February 21st

AstraZeneca PLC (OTCMKTS:AZNCFGet Free Report) declared a dividend on Friday, February 9th, NASDAQ reports. Stockholders of record on Friday, February 23rd will be paid a dividend of 1.97 per share on Monday, March 25th. The ex-dividend date is Wednesday, February 21st. This is a positive change from AstraZeneca’s previous dividend of $0.93.

AstraZeneca Stock Performance

Shares of AZNCF stock opened at $123.50 on Friday. The firm’s 50 day moving average price is $132.15 and its 200-day moving average price is $132.63. AstraZeneca has a one year low of $120.60 and a one year high of $153.10.

AstraZeneca Company Profile

(Get Free Report)

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, andcommercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases.

Further Reading

Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with's FREE daily email newsletter.